Which has preferable earnings & valuation, ASIX or AMTX?

AdvanSix has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AdvanSix $1.52B 0.39 $49.29M $0.37 59.81 Aemetis $197.63M 0.87 -$77M -$1.19 N/A

Is ASIX or AMTX more profitable?

AdvanSix has a net margin of 0.67% compared to Aemetis' net margin of -35.43%. AdvanSix's return on equity of 2.18% beat Aemetis' return on equity. Company Net Margins Return on Equity Return on Assets AdvanSix 0.67% 2.18% 1.05% Aemetis -35.43% N/A -33.44%

Do analysts recommend LXFR or AMTX?

Aemetis has a consensus target price of $8.92, suggesting a potential upside of 263.95%. Given Aemetis' higher probable upside, analysts plainly believe Aemetis is more favorable than Luxfer. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Luxfer 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 3.33 Aemetis 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has preferable valuation & earnings, LXFR or AMTX?

Luxfer has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Luxfer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Luxfer $384.60M 1.22 $7.70M $0.22 78.89 Aemetis $197.63M 0.87 -$77M -$1.19 N/A

Is LXFR or AMTX more profitable?

Luxfer has a net margin of 1.56% compared to Aemetis' net margin of -35.43%. Luxfer's return on equity of 12.14% beat Aemetis' return on equity. Company Net Margins Return on Equity Return on Assets Luxfer 1.56% 12.14% 7.25% Aemetis -35.43% N/A -33.44%

Which has higher valuation and earnings, AMTX or OEC?

Orion has higher revenue and earnings than Aemetis. Orion is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aemetis $197.63M 0.87 -$77M -$1.19 N/A Orion $1.81B 0.23 -$70.10M -$1.60 N/A

Is AMTX or OEC more profitable?

Orion has a net margin of -4.98% compared to Aemetis' net margin of -35.43%. Orion's return on equity of 2.23% beat Aemetis' return on equity. Company Net Margins Return on Equity Return on Assets Aemetis -35.43% N/A -33.44% Orion -4.98% 2.23% 0.47%

Which has preferable earnings & valuation, ALTO or AMTX?

Alto Ingredients has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Alto Ingredients, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alto Ingredients $917.93M 0.47 $13.34M $0.37 14.95 Aemetis $197.63M 0.87 -$77M -$1.19 N/A

Is ALTO or AMTX more profitable?

Alto Ingredients has a net margin of 3.20% compared to Aemetis' net margin of -35.43%. Alto Ingredients' return on equity of 9.77% beat Aemetis' return on equity. Company Net Margins Return on Equity Return on Assets Alto Ingredients 3.20% 9.77% 5.81% Aemetis -35.43% N/A -33.44%

Aemetis (AMTX) Competitors

$2.45 -0.13 (-5.04%)

Closing price 04:00 PM Eastern

Extended Trading

$2.38 -0.07 (-2.98%)

As of 07:59 PM Eastern

Compare

AMTX vs. ASIX, ADUR, LXFR, OEC, and ALTO

Should you buy Aemetis stock or one of its competitors? MarketBeat compares Aemetis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aemetis include AdvanSix (ASIX), Aduro Clean Technologies (ADUR), Luxfer (LXFR), Orion (OEC), and Alto Ingredients (ALTO). These companies are all part of the "chemicals" industry.

How does Aemetis compare to AdvanSix?

AdvanSix (NYSE:ASIX) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

AdvanSix has a net margin of 0.67% compared to Aemetis' net margin of -35.43%. AdvanSix's return on equity of 2.18% beat Aemetis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdvanSix	0.67%	2.18%	1.05%
Aemetis	-35.43%	N/A	-33.44%

In the previous week, Aemetis had 1 more articles in the media than AdvanSix. MarketBeat recorded 1 mentions for Aemetis and 0 mentions for AdvanSix. Aemetis' average media sentiment score of 1.86 beat AdvanSix's score of 0.00 indicating that Aemetis is being referred to more favorably in the news media.

Company	Overall Sentiment
AdvanSix	Neutral
Aemetis	Very Positive

AdvanSix has a beta of 1.28, suggesting that its stock price is 28% more volatile than the broader market. Comparatively, Aemetis has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market.

AdvanSix has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdvanSix	$1.52B	0.39	$49.29M	$0.37	59.81
Aemetis	$197.63M	0.87	-$77M	-$1.19	N/A

86.4% of AdvanSix shares are held by institutional investors. Comparatively, 27.0% of Aemetis shares are held by institutional investors. 5.0% of AdvanSix shares are held by insiders. Comparatively, 13.0% of Aemetis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

AdvanSix presently has a consensus target price of $22.50, suggesting a potential upside of 1.67%. Aemetis has a consensus target price of $8.92, suggesting a potential upside of 263.95%. Given Aemetis' stronger consensus rating and higher possible upside, analysts clearly believe Aemetis is more favorable than AdvanSix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdvanSix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Aemetis	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

AdvanSix and Aemetis tied by winning 8 of the 16 factors compared between the two stocks.

How does Aemetis compare to Aduro Clean Technologies?

Aduro Clean Technologies (NASDAQ:ADUR) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

Aduro Clean Technologies has a beta of 3.15, suggesting that its stock price is 215% more volatile than the broader market. Comparatively, Aemetis has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market.

27.0% of Aemetis shares are held by institutional investors. 13.0% of Aemetis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Aduro Clean Technologies has higher earnings, but lower revenue than Aemetis. Aduro Clean Technologies is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aduro Clean Technologies	$170K	3,132.26	-$8.70M	-$0.44	N/A
Aemetis	$197.63M	0.87	-$77M	-$1.19	N/A

In the previous week, Aduro Clean Technologies had 4 more articles in the media than Aemetis. MarketBeat recorded 5 mentions for Aduro Clean Technologies and 1 mentions for Aemetis. Aemetis' average media sentiment score of 1.86 beat Aduro Clean Technologies' score of 1.20 indicating that Aemetis is being referred to more favorably in the news media.

Company	Overall Sentiment
Aduro Clean Technologies	Positive
Aemetis	Very Positive

Aduro Clean Technologies currently has a consensus price target of $29.00, indicating a potential upside of 84.24%. Aemetis has a consensus price target of $8.92, indicating a potential upside of 263.95%. Given Aemetis' higher probable upside, analysts plainly believe Aemetis is more favorable than Aduro Clean Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aduro Clean Technologies	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Aemetis	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Aemetis has a net margin of -35.43% compared to Aduro Clean Technologies' net margin of -6,393.09%. Aemetis' return on equity of 0.00% beat Aduro Clean Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aduro Clean Technologies	-6,393.09%	-85.29%	-70.27%
Aemetis	-35.43%	N/A	-33.44%

Summary

Aemetis beats Aduro Clean Technologies on 9 of the 16 factors compared between the two stocks.

How does Aemetis compare to Luxfer?

Luxfer (NYSE:LXFR) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

Luxfer has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Luxfer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Luxfer	$384.60M	1.22	$7.70M	$0.22	78.89
Aemetis	$197.63M	0.87	-$77M	-$1.19	N/A

Luxfer has a beta of 1.13, indicating that its stock price is 13% more volatile than the broader market. Comparatively, Aemetis has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

Aemetis has a consensus target price of $8.92, suggesting a potential upside of 263.95%. Given Aemetis' higher probable upside, analysts plainly believe Aemetis is more favorable than Luxfer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Luxfer	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.33
Aemetis	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

90.8% of Luxfer shares are owned by institutional investors. Comparatively, 27.0% of Aemetis shares are owned by institutional investors. 1.2% of Luxfer shares are owned by company insiders. Comparatively, 13.0% of Aemetis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Luxfer had 2 more articles in the media than Aemetis. MarketBeat recorded 3 mentions for Luxfer and 1 mentions for Aemetis. Aemetis' average media sentiment score of 1.86 beat Luxfer's score of 0.82 indicating that Aemetis is being referred to more favorably in the news media.

Company	Overall Sentiment
Luxfer	Positive
Aemetis	Very Positive

Luxfer has a net margin of 1.56% compared to Aemetis' net margin of -35.43%. Luxfer's return on equity of 12.14% beat Aemetis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Luxfer	1.56%	12.14%	7.25%
Aemetis	-35.43%	N/A	-33.44%

Summary

Luxfer beats Aemetis on 12 of the 17 factors compared between the two stocks.

How does Aemetis compare to Orion?

Aemetis (NASDAQ:AMTX) and Orion (NYSE:OEC) are both small-cap chemicals companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

27.0% of Aemetis shares are owned by institutional investors. Comparatively, 94.3% of Orion shares are owned by institutional investors. 13.0% of Aemetis shares are owned by company insiders. Comparatively, 3.1% of Orion shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Aemetis has a beta of 1.36, meaning that its share price is 36% more volatile than the broader market. Comparatively, Orion has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market.

In the previous week, Orion had 3 more articles in the media than Aemetis. MarketBeat recorded 4 mentions for Orion and 1 mentions for Aemetis. Aemetis' average media sentiment score of 1.86 beat Orion's score of 0.43 indicating that Aemetis is being referred to more favorably in the media.

Company	Overall Sentiment
Aemetis	Very Positive
Orion	Neutral

Aemetis presently has a consensus price target of $8.92, indicating a potential upside of 263.95%. Orion has a consensus price target of $5.92, indicating a potential downside of 18.38%. Given Aemetis' stronger consensus rating and higher possible upside, analysts plainly believe Aemetis is more favorable than Orion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aemetis	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Orion	3 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.40

Orion has higher revenue and earnings than Aemetis. Orion is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aemetis	$197.63M	0.87	-$77M	-$1.19	N/A
Orion	$1.81B	0.23	-$70.10M	-$1.60	N/A

Orion has a net margin of -4.98% compared to Aemetis' net margin of -35.43%. Orion's return on equity of 2.23% beat Aemetis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aemetis	-35.43%	N/A	-33.44%
Orion	-4.98%	2.23%	0.47%

Summary

Aemetis beats Orion on 9 of the 16 factors compared between the two stocks.

How does Aemetis compare to Alto Ingredients?

Alto Ingredients (NASDAQ:ALTO) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

Alto Ingredients has a net margin of 3.20% compared to Aemetis' net margin of -35.43%. Alto Ingredients' return on equity of 9.77% beat Aemetis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alto Ingredients	3.20%	9.77%	5.81%
Aemetis	-35.43%	N/A	-33.44%

Alto Ingredients has a beta of 0.13, meaning that its share price is 87% less volatile than the broader market. Comparatively, Aemetis has a beta of 1.36, meaning that its share price is 36% more volatile than the broader market.

42.4% of Alto Ingredients shares are owned by institutional investors. Comparatively, 27.0% of Aemetis shares are owned by institutional investors. 5.3% of Alto Ingredients shares are owned by insiders. Comparatively, 13.0% of Aemetis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Alto Ingredients currently has a consensus target price of $10.00, indicating a potential upside of 80.83%. Aemetis has a consensus target price of $8.92, indicating a potential upside of 263.95%. Given Aemetis' higher probable upside, analysts clearly believe Aemetis is more favorable than Alto Ingredients.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alto Ingredients	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Aemetis	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Alto Ingredients has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Alto Ingredients, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alto Ingredients	$917.93M	0.47	$13.34M	$0.37	14.95
Aemetis	$197.63M	0.87	-$77M	-$1.19	N/A

In the previous week, Alto Ingredients and Alto Ingredients both had 1 articles in the media. Aemetis' average media sentiment score of 1.86 beat Alto Ingredients' score of 0.47 indicating that Aemetis is being referred to more favorably in the news media.

Company	Overall Sentiment
Alto Ingredients	Neutral
Aemetis	Very Positive

Summary

Alto Ingredients beats Aemetis on 8 of the 14 factors compared between the two stocks.

Get Aemetis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMTX vs. The Competition

Export

Metric	Aemetis	Biofuels Industry	Energy Sector	NASDAQ Exchange
Market Cap	$181.55M	$329.78M	$10.36B	$12.54B
Dividend Yield	N/A	5.58%	10.42%	5.22%
P/E Ratio	-2.06	3.30	19.94	22.53
Price / Sales	0.87	1.40	839.95	112.26
Price / Cash	N/A	15.00	38.70	57.13
Price / Book	-0.53	1.13	4.38	6.72
Net Income	-$77M	-$58.67M	$4.23B	$337.19M
7 Day Performance	-2.39%	-4.35%	1.59%	0.48%
1 Month Performance	-30.40%	-24.57%	-0.24%	5.07%
1 Year Performance	40.80%	18.31%	50.96%	34.25%

Aemetis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMTX Aemetis	3.4793 of 5 stars	$2.45 -5.0%	$8.92 +263.9%	+54.5%	$181.55M	$197.63M	N/A	160	Positive News
ASIX AdvanSix	2.3628 of 5 stars	$22.28 -0.7%	$22.50 +1.0%	-3.8%	$604.96M	$1.55B	60.22	1,410
ADUR Aduro Clean Technologies	2.6704 of 5 stars	$17.16 +1.8%	$29.00 +69.0%	+75.2%	$570.11M	$170K	N/A	N/A	Positive News Analyst Upgrade
LXFR Luxfer	3.4658 of 5 stars	$17.33 +1.8%	N/A	+55.9%	$459.92M	$384.60M	78.78	1,350	Analyst Downgrade
OEC Orion	2.3296 of 5 stars	$7.18 -6.1%	$5.92 -17.5%	-28.8%	$430.81M	$1.79B	N/A	1,639

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AMTX) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aemetis (AMTX) Competitors